<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-77502</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Musculoskeletal manifestations in allogenic hematopoietic stem cell transplantation</dc:title>
<dc:description xml:lang="en">Introduction: Few studies have examined musculoskeletal manifestations after allogenic hematopoietic stem cell transplantation (AHSCT). Objective: To investigate the musculoskeletal symptoms observed after AHSCT for distinct  hematological and non-hematological diseases. Material and methods: We performed a retrospective, observational study through review of medical records. Results: There were 123 patients who underwent AHSCT from 1996 to 2000: 34 children (aged 5 months-14 years) and 81 adults (aged 15-55 years). There were 48 women (39%) and 75 men (61%). Of these patients, 43 (34.90%) had acute graft-versus-host disease (aGVHD). Thirty-three out of 106 patients (31.1%) had chronic GVHD (cGVDH) and 50 patients (40.65%) died during follow-up. Musculoskeletal manifestations were found in 14 patients (13.2%): aseptic necrosis in six (5.6%), scleroderma in five (4.7%), arthralgia and bronchiolitis obliterans in one, polyarthralgia in one, and knee monoarthritis in one. Conclusions: Musculoskeletal manifestations after AHSCT cannot be attributed to a single cause. Inflammatory and fibrosing manifestations can be due to the inflammatory process of cGVHD or to the treatments administered during transplantation(AU)</dc:description>
<dc:creator>García-López, A</dc:creator>
<dc:creator>Hernández-Sánchez, R</dc:creator>
<dc:creator>Uceda, J</dc:creator>
<dc:creator>Parody, R</dc:creator>
<dc:creator>Fernández-Delgado, B</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Hay pocos estudios sobre las manifestaciones osteomusculares tras un trasplante alogénico de  progenitores hematopoyéticos (TPH-ALO). El objetivo del presente estudio es investigar los síntomas osteomusculares observados tras la realización de un TPH-ALO como tratamiento de distintas enfermedades hematológicas y no hematológicas. Material y métodos: Estudio observacional retrospectivo, realizado mediante la revisión de historias clínicas. Resultados: Desde el año 1996 hasta el 2000 se identificó a 123 pacientes sometidos a un TPH-ALO, 34 niños (5 meses-14 años) y 81 adultos (15-55 años). La distribución por sexos fue la siguiente: 48 mujeres (39%) y 75 varones (61%). De estos pacientes, 43 (34,90%) presentaron enfermedad del injerto contra el huésped (EICH) aguda, 33 de 106 (31,1%) presentaron EICH crónica y 50 de los pacientes (40,65%) murieron durante el seguimiento. Catorce (13,2%) presentaron manifestaciones osteomusculares: 6 (5,6%) necrosis aséptica, 5 (4,7%) esclerodermia, uno artralgias y bronquiolitis obliterante, uno poliartralgias y otro monoartritis de rodilla. Conclusiones: Es difícil atribuir los síntomas osteomusculares tras un TPH-ALO a una sola causa. Las manifestaciones inflamatorias y fibrosantes pueden ocurrir debido al proceso inflamatorio de la EICH crónica o por los tratamientos administrados durante el procedimiento(AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);1(2): 112-115, jul.-ago. 2005. tab</dc:source>
<dc:identifier>ibc-77502</dc:identifier>
<dc:title xml:lang="es">Manifestaciones osteomusculares en pacientes sometidos a trasplante alogénico de progenitores hematopoyéticos</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30392^s22027</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d6552^s22067</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6235^s22012</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d32203^s22020</dc:subject>
<dc:type>article</dc:type>
<dc:date>200508</dc:date>
</metadata>
</record>
</ibecs-document>
